Description

Description

Diajard-M 12.5/1000mg is a prescription medicine manufactured by Highnoon Laboratories, combining two active ingredients, Empagliflozin and Metformin, within a single tablet. This fixed-dose combination brings together two complementary mechanisms of blood sugar control, offering a convenient treatment option for adults with type 2 diabetes mellitus who require more than one approach to management. Empagliflozin belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class, working by reducing glucose reabsorption in the kidneys and promoting its removal through urine. Metformin belongs to the biguanide class and works mainly by decreasing glucose production in the liver while improving the body’s sensitivity to insulin. In this particular strength, the Metformin component is present at a higher level compared to some other combinations in the Diajard-M range, making it typically suited for patients whose treatment plan calls for a greater Metformin dose alongside the same level of Empagliflozin. Each pack of Diajard-M 12.5/1000mg contains 14 tablets, produced under the quality standards maintained by Highnoon Laboratories.

Ingredients

Diajard-M 12.5/1000mg contains two active ingredients: Empagliflozin at a strength of 12.5 milligrams and Metformin Hydrochloride at a strength of 1000 milligrams per tablet. The formulation also includes standard inactive excipients such as binding agents, fillers, and film-coating materials, which help maintain the tablet’s stability, appearance, and consistent behavior once ingested. These excipients do not contribute to the therapeutic effect but are necessary for proper tablet formulation and stability.

Dosage Form

Diajard-M 12.5/1000mg is available as an oral film-coated tablet. Each pack contains 14 tablets, providing a supply suited to ongoing treatment as directed by a prescribing physician. Being an oral solid dosage form, it can be swallowed directly with water without requiring special preparation.

Uses

Diajard-M 12.5/1000mg is used to help improve blood sugar control in adults with type 2 diabetes mellitus, particularly in cases where a physician determines that a higher Metformin dose alongside Empagliflozin is appropriate for the patient’s individual needs. It is typically used alongside dietary changes and regular physical activity as part of an overall diabetes management plan. This medicine is not intended for individuals with type 1 diabetes or for the management of diabetic ketoacidosis. The suitability of this combination for any individual patient should always be assessed by a qualified healthcare provider.

How to Use

Diajard-M 12.5/1000mg should be taken exactly as prescribed by a physician, usually with meals to help reduce the stomach-related discomfort that can be associated with the Metformin component, especially at this higher strength. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. Consistency in timing is generally encouraged to help maintain steady blood sugar control throughout the day. Patients should continue following any dietary or lifestyle guidance given by their doctor and must not adjust the dosage independently. Regular monitoring of blood sugar levels and kidney function is often recommended while using this combination medicine.

Side Effects

Diajard-M 12.5/1000mg may cause side effects in some individuals, though not everyone experiences them. Commonly reported effects include gastrointestinal discomfort such as nausea, diarrhea, or stomach upset, which may be more noticeable at this higher Metformin strength, particularly during the initial period of use, along with effects associated with the Empagliflozin component such as urinary tract infections, genital yeast infections, and increased urination. Some patients may also experience mild dizziness or symptoms related to dehydration. A rare but serious risk associated with Metformin-containing medicines is lactic acidosis, which can present as unusual muscle pain, difficulty breathing, stomach discomfort, or extreme tiredness, and requires immediate medical attention if suspected. Patients with kidney or liver concerns, a history of heavy alcohol use, or those undergoing procedures involving contrast dye should inform their doctor before using this medicine.

Pregnancy & Breastfeeding

The use of Diajard-M 12.5/1000mg during pregnancy or breastfeeding should only take place under the specific direction of a qualified healthcare provider, as its suitability in these situations depends on individual clinical circumstances. Women who are pregnant, planning pregnancy, or breastfeeding should discuss their situation with their doctor before starting or continuing this combination medicine.

Storage Instructions

Diajard-M 12.5/1000mg tablets should be stored in a cool, dry place away from direct sunlight and moisture, at the room temperature indicated on the packaging. Tablets should remain in their original blister pack until use to help protect them from humidity and light exposure. Keep out of reach of children and pets, and avoid storing in areas prone to temperature changes, such as bathrooms or vehicles.

FAQS

Q: How is Diajard-M 12.5/1000mg different from the 12.5/500mg version?
It contains a higher strength of Metformin while keeping the same Empagliflozin dose, and is typically prescribed when a greater Metformin dose is clinically needed.

Q: Should Diajard-M 12.5/1000mg be taken with food?
Yes, taking it with meals is generally recommended to help minimize stomach-related side effects linked to the higher Metformin strength.

Q: Can Diajard-M 12.5/1000mg replace insulin therapy?
No, it works differently from insulin and is not a substitute for insulin therapy in patients who require it.

Q: What should I do if I miss a dose of Diajard-M 12.5/1000mg?
A missed dose should be taken as soon as remembered unless it is close to the next scheduled dose, in which case the missed dose should be skipped rather than doubled, as advised by a doctor.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.